Spyre Therapeutics, Inc. SYRE
- SPY002 — Ulcerative Colitis Phase 2
- SPY002 — Crohn's Disease Phase 2
- SPY120 — Ulcerative Colitis Phase 2
- SPY230 — Ulcerative Colitis Phase 2
- SPY772 — Hidradenitis Suppurativa Preclinical
TL1A (4 companies · 11 programs)
Companies with an active program directed at TL1A.
Xencor Inc XNCR
- XmAb942 — Ulcerative Colitis Phase 2
- XmAb942 — Crohn's Disease Phase 1
- XmAb412 — Crohn's Disease Phase 1
- XmAb412 — Ulcerative Colitis Phase 1
Absci Corporation ABSI
- ABS-101 — Inflammatory Bowel Disease Phase 1
Oruka Therapeutics, Inc. ORKA
- ORKA-004